한글목차

뉴로모듈레이션 기기 시장은 2025년에 187억 1,000만 달러로 추정되며, 2032년까지 503억 8,000만 달러에 달할 것으로 예측됩니다. 2025-2032년 CAGR 15.2%로 성장할 것으로 전망되고 있습니다.

뉴로모듈레이션 기기는 전기 신호, 약물, 기타 형태의 에너지를 이용한 신경 자극을 통해 통증 신호가 뇌에 도달하기 전에 그 전달을 차단하여 통증을 완화시켜 줍니다. 뉴로모듈레이션 기기는 이식형 의료기기로, 전기 자극이나 약물 투여를 통해 일부 만성질환에 대한 치료적 해결책을 제공합니다. 뉴로모듈레이션 장비는 크게 5가지 기술 분야로 분류됩니다. 즉, 척수자극기, 심부뇌자극기, 미주신경자극기, 천골신경자극기, 위전기자극기 등입니다. 뉴로모듈레이션 기기는 난청, 만성통증, 파킨슨병 등의 질환을 치료하고 신경과 뇌에 전기적 자극을 전달합니다. 전기자극치료는 신경질환에 따른 척수손상이나 근력저하를 치료하기 위해 전기치료를 이용하는 치료법입니다. 전기적 임펄스를 활성화하여 신경조절 기기의 전극에 신호를 전달하는 특성이 있으며, 이로 인해 탈분극이 일어나고 결과적으로 통증 완화 및 근력 향상을 기대할 수 있습니다. 다양한 유형의 전기자극기가 통증관리, 비만 등 다양한 질환의 치료를 목적으로 설계되어 있습니다.

시장 역학

규제 당국의 제품 승인 증가는 예측 기간 중 세계 신경조절 기기 시장의 성장을 가속할 것으로 예측됩니다. 예를 들어 2023년 4월 19일 의료 기술 기업 바이오트로닉(BIOTRONIK)은 척수 자극(SCS) 시스템 '프로스페라(Prospera)'가 미국 식품의약국(FDA)의 승인을 받았다고 발표했습니다. 이 시스템은 최초의 다상 자극 패러다임인 'RESONANCE'를 탑재하고 환자 중심 케어 모델 'Embrace One'과 결합하여 자동적이고 객관적인 일일 원격 모니터링, 지속적인 관리 및 지원을 제공하여 능동적인 케어를 가능하게 합니다. 이번 승인은 바이오트로닉의 새로운 사업 부문인 '바이오트로닉 뉴로(BIOTRONIK Neuro)'의 출범을 의미합니다.

본 조사의 주요 특징

• 이 보고서는 2024년을 기준 연도, 2025-2032년까지의 예측 기간 중 시장 규모와 연평균 성장률(CAGR)을 제시하는 세계 신경조절 장비 시장에 대한 상세한 분석을 제공합니다.
• 다양한 부문의 잠재적 매출 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 이 보고서는 시장 성장 촉진요인, 제약요인, 기회, 신제품 출시 또는 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략에 대한 중요 인사이트를 제공합니다.
• 이 보고서는 다음과 같은 매개변수(기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략)를 기반으로 세계 신경조절 장치 시장의 주요 기업을 프로파일링합니다.
• 본 조사의 대상이 된 주요 기업에는 Medtronic, BD, LivaNova, Axonics, Inc., ShiraTronics, Abbott, Bioventus, Neuronetics, NEVRO CORP, Integer Holdings Corporation, BIOTRONIK, NeuroPace, Inc., NeuroMetrix, Inc., Helius Medical Technologies, Inc., and Synapse Biomedical Inc.가 포함됩니다.
• 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
• 세계 신경조절 장치 시장에 대한 이 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자에게 도움이 될 수 있습니다.
• 이해관계자들은 세계 신경조절 기기 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.

목차

제1장 조사 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 범위

• 리포트 개요
  • 시장 정의와 범위
• 개요
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제 및 동향 분석

• 시장 역학
  • 촉진요인
  • 억제요인
  • 시장 기회
• 영향 분석
• 규제 가이드라인
• 제품 발매
• 주요 발전
• PEST 분석
• Porter의 산업 분석
• 규제 시나리오
• 합병·인수
• 제조업체 매출
• 국가별 의료 지출

제4장 세계의 뉴로모듈레이션 기기 시장 : 기기 유형별, 2020-2032년

• 개요
• 척수 자극 기기
• 심부뇌자극 기기
• 천골신경 자극 기기
• 미주신경 자극 기기
• 위전기 자극 기기

제5장 세계의 뉴로모듈레이션 기기 시장 : 용도별, 2020-2032년

• 개요
• 통증 관리
• 신경질환 및 운동장애 관리
• 근골격계 질환 관리
• 대사 및 소화기계 질환 관리
• 기타(요실금 관리 등)

제6장 세계의 뉴로모듈레이션 기기 시장 : 최종사용자별, 2020-2032년

• 개요
• 병원
• 외래 수술 센터
• 전문 클리닉
• 기타(물리치료 센터 등)

제7장 세계의 뉴로모듈레이션 기기 시장 : 지역별, 2020-2032년

• 북미
  • 미국
  • 캐나다
• 라틴아메리카
  • 브라질
  • 멕시코
  • 아르헨티나
  • 기타 라틴아메리카 국가
• 유럽
  • 영국
  • 독일
  • 이탈리아
  • 프랑스
  • 스페인
  • 러시아
  • 기타 유럽
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • ASEAN
  • 호주
  • 한국
  • 기타 아시아태평양
• 중동
  • GCC
  • 이스라엘
  • 기타 중동
• 아프리카
  • 북아프리카
  • 중앙아프리카
  • 남아프리카공화국

제8장 경쟁 구도

• Medtronic
• BD
• LivaNova
• Axonics, Inc.
• ShiraTronics
• Abbott
• Bioventus
• Neuronetics
• NEVRO CORP
• Integer Holdings Corporation
• BIOTRONIK
• NeuroPace, Inc.
• NeuroMetrix, Inc.
• Helius Medical Technologies, Inc.
• Synapse Biomedical Inc.

제9장 섹션

• 조사 방법
• 출판사 소개

영문목차

Neuromodulation Devices Market is estimated to be valued at USD 18.71 Bn in 2025 and is expected to reach USD 50.38 Bn by 2032, growing at a compound annual growth rate (CAGR) of 15.2% from 2025 to 2032.

Neuromodulation devices stimulate nerves with electrical signals, pharmaceutical agents, or other forms of energy neurostimulation that provides pain relief by blocking the transmission of pain signals before they reach the brain. Neuromodulation devices are implantable medical devices, which introduce therapeutic solutions to some chronic diseases through electric stimulation or medication. Neuromodulation devices are segmented into five major technologies, namely: spinal cord stimulation devices, deep brain stimulation devices, vagus nerve stimulation devices, sacral nerve stimulation devices and gastric electric stimulation devices. Neuromodulation devices deliver electrical impulses to the nerves and the brain by treating disorders such as deafness, chronic pain, and Parkinson's disease. Lectrical stimulation uses electrotherapy for treating spinal injuries and muscle weakness associated with neurological disorders. It has a property to activate electrical impulse and transmit signals to the electrodes of neuromodulation device, which causes depolarization and, in turn, reduces pain and improves the muscle strength. Different types of electrical stimulation devices are designed to treat various diseases such as pain management, obesity, and others.

Market Dynamics

Increasing product approvals by regulatory authorities are expected to drive the global neuromodulation devices market growth over the forecast period. For instance, on April 19, 2023, BIOTRONIK, a medical technology company, announced the U.S. Food and Drug Administration (FDA) approval for Prospera, a Spinal Cord Stimulation (SCS) system. The system features RESONANCE, the first and multiphase stimulation paradigm, paired with Embrace One, a patient-centric care model that makes proactive care possible by offering automatic, objective, daily remote monitoring, and ongoing management and support. This approval marks the launch of the company's new business segment, BIOTRONIK Neuro.

Key features of the study

• This report provides an in-depth analysis of the global neuromodulation devices market, and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global neuromodulation devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• The key companies covered as a part of this study include Medtronic, BD, LivaNova, Axonics, Inc., ShiraTronics, Abbott, Bioventus, Neuronetics, NEVRO CORP, Integer Holdings Corporation, BIOTRONIK, NeuroPace, Inc., NeuroMetrix, Inc., Helius Medical Technologies, Inc., and Synapse Biomedical Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type upgrade, market expansion, and marketing tactics
• The global neuromodulation devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neuromodulation devices market

Market Segmentation

• Global Neuromodulation Devices Market, Device Type
  • Spinal Cord Stimulation Devices
  • Deep Brain Stimulation Devices
  • Sacral Nerve Stimulation Devices
  • Vagus Nerve Stimulation Devices
  • Gastric Electric Stimulation Devices
• Global Neuromodulation Devices Market, Application
  • Pain Management
  • Neurological and Movement Disorder Management
  • Musculoskeletal Disorder Management
  • Metabolism and GIT Management
  • Others (Incontinence Management, etc.)
• Global Neuromodulation Devices Market, By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialized Clinics
  • Others (Nursing Facilities, etc.)
• Global Neuromodulation Devices Market, By Region
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East & Africa
  • GCC Countries
  • Israel
  • Rest of Middle East & Africa
• Global Neuromodulation Devices Market Companies
  • Medtronic
  • BD
  • LivaNova
  • Axonics, Inc.
  • ShiraTronics
  • Abbott
  • Bioventus
  • Neuronetics
  • NEVRO CORP
  • Integer Holdings Corporation
  • BIOTRONIK
  • NeuroPace, Inc.
  • NeuroMetrix, Inc.
  • Helius Medical Technologies, Inc.
  • Synapse Biomedical Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Device Type
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trend Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Regulatory Guidelines
• Product launches
• Key Development
• PEST Analysis
• PORTER's Analysis
• Regulatory Scenario
• Mergers and Acquisitions
• Manufacturer Revenue
• Healthcare Spending by Country

4. Global Neuromodulation Devices Market, By Device Type, 2020-2032, (US$ Billion)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Spinal Cord Stimulation Devices
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Deep Brain Stimulation Devices
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Sacral Nerve Stimulation Devices
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Vagus Nerve Stimulation Devices
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Gastric Electric Stimulation Devices
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

5. Global Neuromodulation Devices Market, By Application, 2020-2032, (US$ Billion)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Pain Management
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Neurological and Movement Disorder Management
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Musculoskeletal Disorder Management
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Metabolism and GIT Management
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Others (Incontinence Management, etc.)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

6. Global Neuromodulation Devices Market, By End User, 2020-2032, (US$ Billion)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Hospitals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Ambulatory Surgical Centers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Specialized Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Others (Physiotherapy Centers, etc.)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

7. Global Neuromodulation Devices Market, By Region, 2020-2032, (US$ Billion)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Regions, 2021-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2020- 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020- 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020- 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Billion)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2020- 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020- 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020- 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Billion)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2020- 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020- 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020- 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Billion)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2020- 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020- 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020- 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Billion)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2020- 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020- 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020- 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Billion)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2020- 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020- 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020- 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Regions, 2020-2032, (US$ Billion)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Medtronic
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• BD
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• LivaNova
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Axonics, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• ShiraTronics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Abbott
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Bioventus
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Neuronetics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• NEVRO CORP
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Integer Holdings Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• BIOTRONIK
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• NeuroPace, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• NeuroMetrix, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Helius Medical Technologies, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Synapse Biomedical Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

9. Section

• Research Methodology
• About Us